The scientific and societal significance of biological sex differences has been largely overlooked in recent decades. Females have historically been-and continue to be-underrepresented in preclinical research, clinical drug trials, and drug development. A key reason to intensify research into sex-specific biology is the uneven prevalence, onset, and progression of many diseases, including neurological disorders. For example, some conditions such as autism spectrum disorder and Parkinson’s disease are more common in males, while others like major depressive disorder, Alzheimer’s disease, and multiple sclerosis are more prevalent in females.
Sex differences in the human brain represent a complex and crucial research area with profound implications for both health and disease. Brain masculinization is initiated by a surge in male gonadal hormones during the neonatal period, which shapes long-term brain structure by organizing neural circuits that later support sexual functions after puberty.
These sex-specific differences likely arise from a complex interplay of (epi)genetic and hormonal regulation in both neurons and glial cells. While research has traditionally focused on neurons, the sexual dimorphism of glial cells remains relatively underexplored, despite their essential roles for the survival and functionality of neurons, as well as the homeostasis of their activity.
To gain a deeper understanding of sex-specific brain differences in health and disease, it is crucial to thoroughly investigate the development and function of glial cells in both female and male brains. Although more research projects now include both sexes, a systematic approach to studying sex differences in neuroscience is still lacking.
The SPP 2561 SEX and GLIA program aims to address this gap with two main objectives:
· Understanding Sex-Driven Mechanisms in Glial Biology: To uncover fundamental mechanisms at the intersection of genetics and hormonal influences, with a focus on physiological, transcriptional, and epigenetic regulation.
· Deciphering Functional Consequences of Sex-Specific Glial Biology: To determine how genetic and hormonal differences between males and females affect glial cell function-ideally at the single-cell or cell-type level-and to link molecular changes to cellular phenotypes, thereby identifying transcriptional and epigenetic alterations that contribute to disease.
Hence, the SPP 2561 aims at combining expertise on glial biology, functional genomics, and computational biology to foster projects that allow major advances in understanding sex-specific roles of glial cells and their cross-talk with neurons and ultimately emergence of diseases.


Kick-off Meeting of SPP2561 “Sex and Glia”
Sex-dependent mechanisms of neuroglial cell function in the context of health and disease
From Sep 28th till Oct 1st, Saarland University hosted the kick-off meeting of the new DFG Priority Programme SPP 2561 “SEX and GLIA: Sex-dependent mechanisms of neuroglial cell function in the context of health and disease.” Researchers from multiple institutions across Germany, Luxembourg and Austria came together in Saarbrücken to officially launch the programme and to plan the collaborative projects that will be pursued over the next three years. The programme, coordinated by Professor Julia Schulze-Hentrich and Professor Barbara Di Benedetto, brings together experts in neuroglial biology, neuroscience, and sex-specific research to investigate how biological sex influences the function of glial cells in the healthy and diseased brain. A central aim is to establish common standards and methods, foster interdisciplinary collaboration, and train early-career researchers in this emerging field.
The kick-off featured scientific presentations, discussions on joint projects, and a keynote lecture by Professor Nathalie Rouach (Collège de France, Paris), who spoke on the role of biological sex as a determinant of astrocyte function. Special guests included Vice-President Professor Kray of Saarland University, Professor Frank Kirchhoff, speaker of the Center for Gender-Specific Biology and Medicine (CGBM) and the Mercator fellows Elly Hol and Enrico Glaab who also participated actively in the meeting.
Over the coming three years, SPP 2561 will fund collaborative research projects focused on understanding sex-dependent mechanisms in neuroglial cells, with the long-term goal of improving our knowledge of brain function and neurological disorders.
